Financials
- Market Capitalization 41.5705 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.16
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 5467 | CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1297 USD | +9.08% | +12.88% | +20.09% | +314.38% | 0 USD | ||
| 6285 | ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -68.75% | 0 USD | ||
| 6643 | NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 12.6500 USD | 0.00% | 0.00% | +1.20% | -51.53% | 2.54 B USD | ||
| 6710 | DRTSW Alpha Tau Medical Ltd. - Warrant | 3.7350 USD | -4.72% | -2.73% | -0.13% | +1145.00% | 1.26 B USD |